Two Biosimilar Bills Head to President Biden for Signature Two Biosimilar Bills Head to President BIden for Signature Read More Biosimilars, biologics, biotechnology, Congress, FDA, healthcare, HHS, legislation, pharmaceuticals, prescription drug costsRon LantonApril 20, 2021Advancing Education on Biosimilars Act, Ensuring Innovation Act, biosimilars, life science